21 June 2018 EMA/CVMP/PhVWP/272687/2018 Committee for Medicinal Products for Veterinary Use

List of changes to combined VeDDRA list of clinical terms

1

Application site vasoconstriction

1107

Application site vasoconstriction

2671

1: A: animal; C: common; H: human 2: A: addition; D: deletion; M: modification

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

An agency of the European Union

Current Term Type1

New LLT Key

New LLT

Current LLT Key

Current Low Level Term (LLT)

New PT Key

New PT Term

Current PT Key

Current Preferred Term (PT)

New HLT Key

New HLT Term

Current HLT Key

New SOC Key

Current High Level Term (HLT) Application site reactions

Action2

1

New SOC Term

Current SOC Key

Application site disorders

New Term Type1

1

Current System Organ Class (SOC) Term

Change no.

For reporting suspected adverse reactions in animal and humans to veterinary medicinal products for 2018

C

A

Current Term Type1

New Term Type1

Action2

Inappropriate elimination NOS

2674

C

A

137

Hypovolaemic shock

2675

C

A

Phlebitis

151

Thrombophlebitis

2676

C

A

Intestinal stasis

628

Hard stool

2677

C

A

3

Behavioural disorders

2

Other behavioural disorders

6

4

Behavioural disorders

2

Other behavioural disorders

6

5

Cardiovascular system disorders

4

Circulatory disorders

24

Circulatory shock

6

Cardiovascular system disorders

4

Vascular disorders

27

7

Digestive tract disorders

5

Intestinal disorders

236

2

Hyperactivity

1108

73

Inappropriate elimination NOS

1109

Puncture wound

2672

Unsettled

New LLT

New LLT Key

A

Puncture wound

Current LLT Key

C

3

New PT Key

2673

Injection site reactions

New PT Term

M

1

Current PT Key

H

Application site disorders

1

Current Low Level Term (LLT)

Current Preferred Term (PT)

New HLT Key

New HLT Term

Current HLT Key

Current High Level Term (HLT)

New SOC Key

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no.

C

2

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 2/41

Action2

Endocrine system disorders

7

Thyroid gland disorders

51

Thyroid gland disorder NOS

251

Enlarged thyroid gland

2679

C

A

10

Endocrine system disorders

7

Thyroid gland disorders

51

Thyroid gland disorder NOS

251

Goitre

2680

C

A

11

Immune system disorders

10

Autoimmune disorders

70

Immunemediated polyarthropathy

1110

Immunemediated polyarthritis

2681

C

A

12

Immune system disorders

10

Autoimmune disorders

70

Immunemediated polyarthropathy

1110

Immunemediated polyarthropathy

2682

C

A

13

Systemic disorders

19

General signs or symptoms

154

Abnormal cytology

1089

1 2

Investigations

34

Abnormal cytology

26 4

Abnormal test result

666

Abnormal cytology

2588

New LLT Key

9

New LLT

A

Current LLT Key

C

New PT Key

2678

New PT Term

Reduced faecal output

Current PT Key 628

New HLT Key

Intestinal stasis

New HLT Term

236

Current HLT Key

Intestinal disorders

New SOC Key

5

New SOC Term

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term Digestive tract disorders

Change no. 8

C

M

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 3/41

2070

15

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Abnormal imaging

26 6

Abnormal test result

666

Abnormal ultrasound finding

1093

Abnormal ultrasound finding

2069

16

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Abnormal necropsy

26 5

Abnormal test result

666

Abnormal necropsy finding

1090

Abnormal necropsy finding

2142

17

Investigations

34

Abnormal physical examination

27 0

Abnormal rectal palpation

18

Investigations

34

Adrenal investigations

25 3

19

Investigations

34

Adrenal investigations

25 3

Abnormal adrenocorticotropic hormone (ACTH) stimulation test Abnormal dexamethasone suppression test

Current SOC Key 1 2

2070

C

M

C

M

C

M

Action2

Abnormal radiograph finding

New Term Type1

1091

Current Term Type1

Abnormal radiograph finding

New LLT Key

666

Current LLT Key

Abnormal test result

New LLT

Current Low Level Term (LLT)

26 6

New PT Key

Abnormal imaging

New PT Term

Current Preferred Term (PT)

154

Current PT Key

New HLT Key

General signs or symptoms

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

19

Current System Organ Class (SOC) Term Systemic disorders

Change no. 14

NT - Abnormal necropsy finding NOS

2142

1111

Abnormal rectal palpation

2683

C

A

1042

Abnormal adrenocorticotropic hormone (ACTH) stimulation test

2663

C

A

1041

Abnormal dexamethasone suppression test

2662

C

A

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 4/41

Current Low Level Term (LLT)

2624

C

M

21

Endocrine system disorders

7

Investigations

34

Adrenal gland disorders

45

Adrenal investigations

25 3

Hypoadrenocorticism

237

Hypocortisolaemia

1044

Hypocortisolaemia

2625

C

M

22

Blood and lymphatic system disorders

3

Investigations

34

Bone marrow disorders

12

Bone marrow investigations

24 6

Bone marrow aplasia

89

Bone marrow hypoplasia

1022

Bone marrow aplasia

149

C

M

23

Blood and lymphatic system disorders

3

Investigations

34

Bone marrow disorders

12

Bone marrow investigations

24 6

Bone marrow aplasia

89

Bone marrow hypoplasia

1022

Bone marrow hypoplasia

2385

C

M

24

Blood and lymphatic system disorders

3

Investigations

34

Bone marrow disorders

12

Bone marrow investigations

24 6

Bone marrow aplasia

89

Bone marrow hypoplasia

1022

Bone marrow suppression

150

C

M

25

Blood and lymphatic system disorders

3

Investigations

34

Bone marrow disorders

12

Bone marrow investigations

24 6

Bone marrow aplasia

89

Bone marrow hypoplasia

1022

Pancytopenia

2114

C

M

Current SOC Key 1 2

Action2

Hypercortisolaemia

New Term Type1

1043

Current Term Type1

Hypercortisolaemia

New LLT Key

236

New LLT

Hyperadrenocorticism

Current LLT Key

25 3

New PT Key

Adrenal investigations

New PT Term

Current Preferred Term (PT)

45

Current PT Key

New HLT Key

Adrenal gland disorders

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

7

Current System Organ Class (SOC) Term Endocrine system disorders

Change no. 20

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 5/41

Current Low Level Term (LLT)

M

27

Blood and lymphatic system disorders

3

Investigations

34

Bone marrow disorders

12

Bone marrow investigations

24 6

Bone marrow disorder NOS

877

Bone marrow disorder NOS

1882

C

M

28

Blood and lymphatic system disorders

3

Investigations

34

Coagulation abnormalities

13

Coagulation investigations

24 7

Other coagulation abnormality

90

Coagulopathy

1023

Coagulopathy

1057

C

M

29

Blood and lymphatic system disorders

3

Investigations

34

Coagulation abnormalities

13

Coagulation investigations

24 7

Thrombosis

91

Disseminated intravascular coagulation

1026

Disseminated intravascular coagulation

154

C

M

30

Blood and lymphatic system disorders

3

Investigations

34

Coagulation abnormalities

13

Coagulation investigations

24 7

Other coagulation abnormality

90

Increased coagulation time

1024

Increased coagulation time

2209

C

M

31

Blood and lymphatic system disorders

3

Investigations

34

Coagulation abnormalities

13

Coagulation investigations

24 7

Other coagulation abnormality

90

Increased coagulation time

1024

Prolonged activated partial thrombin time (APTT)

2210

C

M

Current SOC Key 1 2

Action2

C

New Term Type1

146

Current Term Type1

Aplastic anaemia

New LLT Key

86

New LLT

Aplastic anaemia

Current LLT Key

24 6

New PT Key

Bone marrow investigations

New PT Term

Current Preferred Term (PT)

212

Current PT Key

New HLT Key

Disorders of red blood cells

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

3

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 26

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 6/41

Other coagulation abnormality

90

Increased coagulation time

1024

Prolonged one stage prothrombin time (OSPT)

2211

33

Blood and lymphatic system disorders

3

Investigations

34

Coagulation abnormalities

13

Coagulation investigations

24 7

Other coagulation abnormality

90

Other coagulation abnormality NOS

1025

Other coagulation abnormality

152

34

Eye disorders

8

Investigations

34

Scleral and conjunctival disorders

64

Conjunctival investigations

25 7

Keratoconjunctivitis sicca

293

Dry eye

35

Eye disorders

8

Investigations

34

Scleral and conjunctival disorders

64

Conjunctival investigations

25 7

Keratoconjunctivitis sicca

293

Investigations

34

Conjunctival investigations

25 7

Schirmer tear test

105 1

Investigations

34

Electrolyte investigations

26 0

Acid-base disorder

337

36

37

Metabolism and nutrition disorders

1 2

12

Electrolyte and fluid balance disorders

79

Acidosis

1056

Action2

24 7

New Term Type1

Coagulation investigations

Current Term Type1

13

New LLT Key

Coagulation abnormalities

New PT Key

34

New PT Term

Investigations

New LLT

Current LLT Key

Current Low Level Term (LLT)

Current PT Key

Current Preferred Term (PT)

New HLT Key

3

New SOC Key

New HLT Term

Current HLT Key

Current High Level Term (HLT)

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 32

C

M

C

M

472

C

M

Keratoconjunctivitis sicca

471

C

M

Schirmer tear test

2666

Acidosis

1898

Other coagulation abnormality NOS

152

C

C

A

M

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 7/41

2075

High ionized calcium (Ca; Hypercalcemia, ionized)

1112

C

High ionized calcium (Ca; Hypercalcemia, ionized)

2684

Action2

Alkalosis

New Term Type1

1057

Current Term Type1

26 0

Alkalosis

New LLT Key

Electrolyte investigations

337

New LLT

Acid-base disorder

Current LLT Key

26 0

Current Low Level Term (LLT)

Electrolyte investigations

New PT Key

Current HLT Key 79

New PT Term

34

Electrolyte and fluid balance disorders

Current PT Key

Investigations

Current High Level Term (HLT)

New SOC Key 34

Current Preferred Term (PT)

39

Investigations

New HLT Key

12

New HLT Term

Metabolism and nutrition disorders

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no. 38

M

C

A

40

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

Electrolyte disorder

951

High sodiumpotassium ratio (Na:K ratio)

1058

High sodiumpotassium ratio (Na:K ratio)

2629

C

M

41

Metabolism and nutrition disorders

12

Investigations

34

Other metabolic disorders

82

Electrolyte investigations

26 0

Hypercalcaemic condition

343

Hypercalcaemia

343

Hypercalcaemia

553

C

M

42

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

Electrolyte disorder

951

Hyperchloraemia

1059

Hyperchloraemia

2577

C

M

43

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

Electrolyte disorder

951

Hyperkalaemia

1060

Hyperkalaemia

1944

C

M

1 2

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 8/41

Current Low Level Term (LLT)

2511

C

M

45

Metabolism and nutrition disorders

12

Investigations

34

Other metabolic disorders

82

Electrolyte investigations

26 0

Changes in blood phosphorous

930

Hyperphosphataemia

1066

Hyperphosphataemia

2046

C

M

Investigations

34

Electrolyte investigations

26 0

Hypocalcaemia

1113

Current SOC Key

46

Hypocalcaemia

2685

C

Action2

Hypernatremia

New Term Type1

1061

Current Term Type1

Hypernatremia

New LLT Key

951

New LLT

Electrolyte disorder

Current LLT Key

26 0

New PT Key

Electrolyte investigations

New PT Term

Current Preferred Term (PT)

79

Current PT Key

New HLT Key

Electrolyte and fluid balance disorders

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

12

Current System Organ Class (SOC) Term Metabolism and nutrition disorders

Change no. 44

A

47

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

Electrolyte disorder

951

Hypochloraemia

1062

Hypochloraemia

2578

C

M

48

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

Electrolyte disorder

951

Hypokalaemia

1063

Hypokalaemia

2418

C

M

49

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

Electrolyte disorder

951

Hyponatremia

1064

Hyponatremia

2512

C

M

1 2

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 9/41

51

34

Investigations

34

Other metabolic disorders

82

52

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

Electrolyte disorder

951

53

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

Acid-base disorder

54

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

55

Metabolism and nutrition disorders

12

Investigations

34

Electrolyte and fluid balance disorders

79

Electrolyte investigations

26 0

1 2

Hypophosphataemia

1067

Low ionized calcium (Ca; Hypocalcaepocalcaemia, ionized) Low sodiumpotassium ratio (Na:K ratio)

1114

1065

Hypophosphataemia

2242

C

Low ionized calcium (Ca; Hypocalcaemia, ionized)

2686

Action2

New Term Type1

Current Term Type1

New LLT Key

New LLT

Current LLT Key

Current Low Level Term (LLT)

26 0

930

New PT Key

Electrolyte investigations

Changes in blood phosphorous

New PT Term

26 0

Current PT Key

Electrolyte investigations

Current Preferred Term (PT)

Current HLT Key

Current High Level Term (HLT)

New SOC Key

Investigations

New HLT Key

12

New HLT Term

Metabolism and nutrition disorders

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no. 50

M

C

A

Low sodiumpotassium ratio (Na:K ratio)

2630

C

M

337

Acid-base disorder

540

C

M

Electrolyte disorder

951

Cervical ventroflexion

2123

C

M

Electrolyte disorder

951

Electrolyte disorder

2144

C

M

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 10/41

Hepatobiliary disorders

9

Investigations

34

Hepatic disorders

66

Hepatobiliary investigations

25 8

Hepatopathy

308

Elevated bile acids

1054

Elevated bile acids

2051

58

Hepatobiliary disorders

9

Investigations

34

Hepatic disorders

66

Hepatobiliary investigations

25 8

Hepatopathy

308

Elevated liver enzymes

1052

Elevated ALT

2050

59

Hepatobiliary disorders

9

Investigations

34

Hepatic disorders

66

Hepatobiliary investigations

25 8

Hepatopathy

308

Elevated liver enzymes

1052

Elevated gammaglutamyl transferase (GGT)

60

Hepatobiliary disorders

9

Investigations

34

Hepatic disorders

66

Hepatobiliary investigations

25 8

Hepatopathy

308

Elevated liver enzymes

1052

61

Hepatobiliary disorders

9

Investigations

34

Hepatic disorders

66

Hepatobiliary investigations

25 8

Hepatopathy

308

Elevated liver enzymes

1052

2

Action2

Current Term Type1

New LLT Key 2687

New Term Type1

Hypercalcaemic condition

57

1

New LLT

Current LLT Key

343

Current Low Level Term (LLT)

Hypercalcaemic condition

New PT Key

26 0

New PT Term

Electrolyte investigations

Current PT Key

Current Preferred Term (PT)

Current HLT Key

New HLT Key

34

New HLT Term

Investigations

Current High Level Term (HLT)

New SOC Key

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no. 56

C

A

C

M

C

M

2238

C

M

Elevated liver enzymes

1942

C

M

Elevated sorbitol dehydrogenase (SDH)

2525

C

M

Elevated alanine aminotransferase (ALT)

2050

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 11/41

Action2 A

63

Investigations

34

Hepatobiliary investigations

25 8

Low liver enzymes

1115

Low liver enzymes

2689

C

A

New LLT Key

C

New LLT

2688

Current LLT Key

Low alanine aminotransferase (ALT)

New PT Key 1115

New PT Term Low liver enzymes

Current PT Key

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

New HLT Key 25 8

Current HLT Key

Hepatobiliary investigations

New SOC Key 34

New SOC Term

New HLT Term

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term

Investigations

Change no. 62

64

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Inflammatory investigations

26 8

Abnormal test result

666

Elevated Creactive protein

1096

Elevated Creactive protein

2267

C

M

65

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Inflammatory investigations

26 8

Abnormal test result

666

Elevated fibrinogen level

1097

Elevated fibrinogen level

2268

C

M

66

Hepatobiliary disorders

9

Investigations

34

Hepatic disorders

66

Investigations NOS

25 9

Hepatopathy

308

Elevated aspartate aminotransferase (AST)

1053

Elevated AST

2049

C

M

67

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Investigations NOS

25 9

Abnormal test result

666

Elevated lactic acid dehydrogenase (LDH)

1099

Elevated lactic acid dehydrogenase (LDH)

2269

C

M

1 2

Elevated aspartate aminotransferase (AST)

2049

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 12/41

Current Low Level Term (LLT)

Current LLT Key

25 9

Abnormal test result

666

Elevated serum alkaline phosphatase (SAP)

1100

Elevated SAP

2055

69

Hepatobiliary disorders

9

Investigations

34

Hepatic disorders

66

Investigations NOS

25 9

Hepatopathy

308

Elevated total bilirubin

1055

Elevated total bilirubin

70

Renal and urinary disorders

15

Investigations

34

Renal disorders

107

Investigations NOS

25 9

Renal insufficiency

428

Increased blood urea nitrogen (BUN) or creatinine

1069

71

Renal and urinary disorders

15

Investigations

34

Renal disorders

107

Investigations NOS

25 9

Renal insufficiency

428

Increased blood urea nitrogen (BUN) or creatinine

72

Renal and urinary disorders

15

Investigations

34

Renal disorders

107

Investigations NOS

25 9

Renal insufficiency

428

73

Renal and urinary disorders

15

Investigations

34

Renal disorders

107

Investigations NOS

25 9

Renal insufficiency

428

2

2052

C

M

Azotaemia

2182

C

M

1069

Elevated BUN

2047

C

M

Increased blood urea nitrogen (BUN) or creatinine

1069

Elevated creatinine

2048

C

M

Increased blood urea nitrogen (BUN) or creatinine

1069

Elevated renal parameters

1992

C

M

Elevated blood urea nitrogen (BUN)

2047

Action2 M

Elevated serum alkaline phosphatase (SAP)

New Term Type1

C

New LLT

2055

New PT Term

Current SOC Key 1

Current Term Type1

New PT Key

Investigations NOS

New LLT Key

Current Preferred Term (PT)

154

Current PT Key

New HLT Key

General signs or symptoms

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

19

Current System Organ Class (SOC) Term Systemic disorders

Change no. 68

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 13/41

Investigations

34

General signs or symptoms

154

1101

Low serum alkaline phosphatase (SAP)

1116

Low fibrinogen level

2270

C

Low serum alkaline phosphatase (SAP)

2690

Action2

New Term Type1

Current Term Type1

New LLT Key

New LLT

25 9

Low fibrinogen level

Current LLT Key

Investigations NOS

666

Current Low Level Term (LLT)

Abnormal test result

New PT Key

25 9

New PT Term

Investigations NOS

Current PT Key

Current HLT Key

Current High Level Term (HLT)

New SOC Key 34

Current Preferred Term (PT)

75

Investigations

New HLT Key

19

New HLT Term

Systemic disorders

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no. 74

M

C

A

76

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Metabolic investigations

25 4

Abnormal test result

666

Decreased cholesterol (total)

1094

Decreased cholesterol (total)

2265

C

M

77

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Metabolic investigations

25 4

Abnormal test result

666

Elevated insulin

1098

Elevated insulin

2545

C

M

78

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Metabolic investigations

25 4

Abnormal test result

666

Elevated serum lipids

1095

Elevated cholesterol (total)

2266

C

M

79

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Metabolic investigations

25 4

Abnormal test result

666

Elevated serum lipids

1095

Elevated triglyceride

2508

C

M

1 2

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 14/41

82

Endocrine system disorders

7

Investigations

34

Pancreas endocrine disorders

48

Metabolic investigations

25 4

Diabetes mellitus

240

83

Metabolism and nutrition disorders

12

Investigations

34

Other metabolic disorders

82

Metabolic investigations

25 4

Ketosis

84

Metabolism and nutrition disorders

12

Investigations

34

Other metabolic disorders

82

Metabolic investigations

25 4

85

Metabolism and nutrition disorders

12

Investigations

34

Other metabolic disorders

82

Metabolic investigations

25 4

1 2

2421

Elevated serum lipids

1095

Glucose intolerance

1045

C

Elevated serum lipids

2667

Action2

Lipaemia

New Term Type1

1095

Current Term Type1

25 4

Elevated serum lipids

New LLT Key

Metabolic investigations

666

New LLT

Abnormal test result

Current LLT Key

25 4

New PT Term

Metabolic investigations

Current PT Key

Current HLT Key 154

Current Low Level Term (LLT)

34

General signs or symptoms

New PT Key

Investigations

Current High Level Term (HLT)

New SOC Key 34

Current Preferred Term (PT)

81

Investigations

New HLT Key

19

New HLT Term

Systemic disorders

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no. 80

M

C

A

Glucose intolerance

392

C

M

351

Acetonaemia

566

C

M

Hyperglycaemia

903

Hyperglycaemia

1946

C

M

Hypoglycaemia

904

Hypoglycaemia

1947

C

M

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 15/41

C

M

Myoglobinuria

371

Equine myoglobinuria

604

A

M

26 1

Myoglobinuria

371

Myoglobinuria

2056

C

M

26 7

Abnormal test result

666

Abnormal test result

1221

C

M

Musculoskeletal disorders

13

Investigations

34

Muscular disorders

89

Muscle investigations

26 1

Myositis

376

88

Musculoskeletal disorders

13

Investigations

34

Muscular disorders

89

Muscle investigations

26 1

Myoglobinuria

89

Musculoskeletal disorders

13

Investigations

34

Muscular disorders

89

Muscle investigations

26 1

90

Musculoskeletal disorders

13

Investigations

34

Muscular disorders

89

Muscle investigations

91

Systemic disorders

19

Investigations

34

General signs or symptoms

154

Other abnormal test result NOS

Current SOC Key 1 2

Current HLT Key

87

New SOC Key

351

New SOC Term

Ketosis

Current System Organ Class (SOC) Term

25 4

Change no.

Metabolic investigations

Elevated creatinekinase (CK)

Other abnormal test result NOS

1068

1092

Other abnormal test result NOS

1221

Action2

605

82

New Term Type1

Azoturia

Other metabolic disorders

Current Term Type1

371

34

New LLT Key

Current LLT Key

M

Investigations

New LLT

Current Low Level Term (LLT)

C

12

New PT Key

2245

Metabolism and nutrition disorders

New PT Term

Elevated creatinekinase (CK)

Current PT Key

M

Current Preferred Term (PT)

C

New HLT Key

567

New HLT Term

Current High Level Term (HLT)

Ketosis

86

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 16/41

Current Low Level Term (LLT)

2232

C

M

93

Digestive tract disorders

5

Investigations

34

Pancreas disorders

37

Pancreatic investigations

25 2

Pancreas disorder

208

Elevated pancreatic enzymes

1040

Elevated lipase

2168

C

M

94

Investigations

34

Pancreatic investigations

25 2

Elevated pancreatic enzymes

1040

Elevated pancreatic enzymes

2661

C

A

95

Investigations

34

Pancreatic investigations

25 2

Elevated pancreatic enzymes

1040

High pancreatic-specific lipase

2692

C

A

96

Investigations

34

Pancreatic investigations

25 2

Elevated pancreatic enzymes

1040

High trypsinlike immunoreactivity (TLI)

2693

C

A

97

Investigations

34

Pancreatic investigations

25 2

Low pancreatic enzymes

1118

Low pancreatic enzymes

2694

C

A

Current SOC Key 1 2

Action2

Elevated amylase

New Term Type1

1040

Current Term Type1

Elevated pancreatic enzymes

New LLT Key

208

New LLT

Pancreas disorder

Current LLT Key

25 2

New PT Key

Pancreatic investigations

New PT Term

Current Preferred Term (PT)

37

Current PT Key

New HLT Key

Pancreas disorders

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

5

Current System Organ Class (SOC) Term Digestive tract disorders

Change no. 92

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 17/41

Action2 A

99

Investigations

34

Parathyroid investigations

25 5

Elevated parathyroid (PTH) concentration

1046

Elevated parathyroid (PTH) concentration

2664

C

A

100

Investigations

34

Parathyroid investigations

25 5

Low parathyroid (PTH) concentration

1047

Low parathyroid (PTH) concentration

2665

C

A

101

Investigations

34

Peritoneal fluid investigations

27 1

Peritoneal fluid, abnormal NOS

1124

Peritoneal fluid, high protein level

2713

C

A

102

Investigations

34

Peritoneal fluid investigations

27 1

Peritoneal fluid, abnormal NOS

1124

Peritoneal fluid, high white blood cell count

2714

C

A

103

Investigations

34

Peritoneal fluid investigations

27 1

Peritoneal fluid, abnormal NOS

1124

Peritoneal fluid, abnormal NOS

2715

C

A

1 2

New LLT Key

C

New LLT

2695

Current LLT Key

Low trypsin-like immunoreactivity (TLI)

New PT Key 1118

New PT Term Low pancreatic enzymes

Current PT Key

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

New HLT Key 25 2

Current HLT Key

Pancreatic investigations

New SOC Key 34

New SOC Term

New HLT Term

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term

Investigations

Change no. 98

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 18/41

Action2 A

105

Investigations

34

Pleural fluid investigations

27 3

Pleural fluid, abnormal NOS

1126

Pleural fluid, high protein level

2717

C

A

106

Investigations

34

Pleural fluid investigations

27 3

Pleural fluid, abnormal NOS

1126

Pleural fluid, high red blood cell count

2718

C

A

107

Investigations

34

Pleural fluid investigations

27 3

Pleural fluid, abnormal NOS

1126

Pleural fluid, high white blood cell count

2719

C

A

108

Investigations

34

Pleural fluid investigations

27 3

Pleural fluid, abnormal NOS

1126

Pleural fluid, abnormal NOS

2720

C

A

109

Investigations

34

Red blood cell investigations

24 9

Agglutination test, positive

1119

Agglutination test, positive

2696

C

A

1 2

New LLT Key

C

New LLT

2716

Current LLT Key

High adrenocorticotropic (ACTH) hormone

New PT Key 1125

New PT Term High adrenocorticotropic (ACTH) hormone

Current PT Key

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

New HLT Key 27 2

Current HLT Key

Pituitary investigations

New SOC Key 34

New SOC Term

New HLT Term

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term

Investigations

Change no. 104

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 19/41

Action2 A

111

Investigations

34

Red blood cell investigations

24 9

Agglutination test, positive

1119

Saline slide agglutination test, positive

2698

C

A

New LLT Key

C

New LLT

2697

Current LLT Key

Direct Coombs test, positive

New PT Key 1119

New PT Term Agglutination test, positive

Current PT Key

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

New HLT Key 24 9

Current HLT Key

Red blood cell investigations

New SOC Key 34

New SOC Term

New HLT Term

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term

Investigations

Change no. 110

112

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Reticulocyte disorders

966

Decreased percentage of reticulocytes

1029

Decreased percentage of reticulocytes

2212

C

M

113

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Reticulocyte disorders

966

Increased percentage reticulocytes

1030

Increased percentage reticulocytes

2213

C

M

114

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Disorder of red blood cell NOS

745

Polycythaemia

1028

Increased packed cell volume (PCV)

2419

C

M

115

Blood and lymphatic system disorders

3

Investigations

34

Other blood disorders

19

Red blood cell investigations

24 9

Increased red blood cell count

101 8

Polycythaemia

1028

Increased red blood cell count

2613

C

M

1 2

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 20/41

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Disorder of red blood cell NOS

118

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

119

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

120

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

121

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Current SOC Key 1 2

Action2

Investigations

New Term Type1

3

Current Term Type1

Blood and lymphatic system disorders

1028

New LLT Key

117

Polycythaemia

New LLT

745

Current LLT Key

Disorder of red blood cell NOS

Current Low Level Term (LLT)

24 9

New PT Key

Red blood cell investigations

New PT Term

Current Preferred Term (PT)

212

Current PT Key

New HLT Key

Disorders of red blood cells

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

3

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 116

Polycythaemia

2521

C

M

745

Abnormal red blood cell

2217

C

M

Anaemia NOS

85

Anaemia NOS

142

C

M

24 9

Anaemia NOS

85

Decreased haemoglobin

2214

C

M

Red blood cell investigations

24 9

Anaemia NOS

85

Decreased packed cell volume (PCV)

2215

C

M

Red blood cell investigations

24 9

Anaemia NOS

85

Decreased red blood cell count

2157

C

M

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 21/41

Current Low Level Term (LLT)

M

123

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Anaemia NOS

85

Haemolysis

2156

C

M

124

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Haemolytic anaemia

87

Haemolytic anaemia

147

C

M

125

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Anaemia NOS

85

Heinz body anaemia

2216

C

M

126

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Anaemia NOS

85

Iron deficiency anaemia

144

C

M

127

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Methaemoglobinaemia

967

Methaemoglobinaemia

2218

C

M

Current SOC Key 1 2

Action2

C

New Term Type1

1416

Current Term Type1

Disorder of red blood cell NOS

New LLT Key

745

New LLT

Disorder of red blood cell NOS

Current LLT Key

24 9

New PT Key

Red blood cell investigations

New PT Term

Current Preferred Term (PT)

212

Current PT Key

New HLT Key

Disorders of red blood cells

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

3

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 122

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 22/41

Current Low Level Term (LLT)

C

M

129

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Disorder of red blood cell NOS

745

Red blood cell disorder

181

C

M

130

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Regenerative anaemia

624

Regenerative anaemia

1056

C

M

131

Blood and lymphatic system disorders

3

Investigations

34

Disorders of red blood cells

212

Red blood cell investigations

24 9

Disorder of red blood cell NOS

745

Spherocytosis

2612

C

M

132

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Acidic urine

1074

Acidic urine

1951

C

M

133

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Alkaline urine

1075

Alkaline urine

1952

C

M

Current SOC Key 1 2

Action2

145

New Term Type1

Nonregenerative anaemia

Current Term Type1

85

New LLT Key

Anaemia NOS

New LLT

24 9

Current LLT Key

Current PT Key

Red blood cell investigations

New PT Key

Current Preferred Term (PT)

212

New PT Term

New HLT Key

Disorders of red blood cells

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

3

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 128

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 23/41

26 2

Decreased blood urea nitrogen (BUN) or creatinine

1120

Low blood urea nitrogen (BUN)

2700

C

A

Renal and urinary investigations

26 2

Decreased blood urea nitrogen (BUN) or creatinine

1120

Low creatinine

2701

C

A

Renal and urinary investigations

26 2

Decreased blood urea nitrogen (BUN) or creatinine

1120

Decreased blood urea nitrogen (BUN) or creatinine

2702

C

A

Investigations

34

137

New HLT Term

34

136

Current HLT Key

Investigations

New SOC Key

Renal and urinary investigations

Investigations

C

Action2

Current LLT Key 2175

34

135

110

New Term Type1

Current Low Level Term (LLT) Bilirubinuria

Urine abnormalities

Urinary tract disorders

Current Term Type1

New PT Key 1076

26 2

34

New LLT Key

New PT Term Bilirubinuria

Renal and urinary investigations

Investigations

New LLT

Current PT Key

Current High Level Term (HLT)

906

Current Preferred Term (PT)

15

New HLT Key

Renal and urinary disorders

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no. 134

M

138

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Decreased urine concentration

1078

Decreased urine concentration

1963

C

M

139

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Decreased urine concentration

1078

Hyposthenuria

2475

C

M

1 2

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 24/41

2533

141

Renal and urinary disorders

15

Investigations

34

Renal disorders

107

Renal and urinary investigations

26 2

Renal insufficiency

428

Elevated symmetrical dimethylarginine (SDMA)

1071

Elevated SDMA (Symmetrical dimethylarginine)

2583

142

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Glucosuria

1079

Glucosuria

143

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Haematuria

1077

144

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Haematuria

145

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Haemoglobinuria

Current SOC Key 1 2

Action2

Elevated protein:creatini ne ratio

New Term Type1

1070

Current Term Type1

Elevated protein:creatini ne ratio

New LLT Key

428

New LLT

Renal insufficiency

Current LLT Key

26 2

Current Low Level Term (LLT)

Current Preferred Term (PT)

Renal and urinary investigations

New PT Key

New HLT Key

107

New PT Term

Current HLT Key

Renal disorders

Current PT Key

Current High Level Term (HLT)

34

New HLT Term

New SOC Key

Investigations

New SOC Term

15

Current System Organ Class (SOC) Term Renal and urinary disorders

Change no. 140

C

M

C

M

1960

C

M

Blood in urine

1956

C

M

1077

Haematuria

1967

C

M

1081

Haemoglobinuria

2027

C

M

Elevated symmetrical dimethylarginine (SDMA)

2583

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 25/41

Current Low Level Term (LLT)

C

M

147

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Increased urine concentration

1082

Increased urine concentration

1962

C

M

148

Renal and urinary disorders

15

Investigations

34

Renal disorders

107

Renal and urinary investigations

26 2

Renal insufficiency

428

Isosthenuria

1072

Isosthenuria

2254

C

M

149

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Proteinuria

1083

Proteinuria

1961

C

M

150

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Pyuria

1084

Pyuria

2255

C

M

151

Renal and urinary disorders

15

Investigations

34

Renal disorders

107

Renal and urinary investigations

26 2

Renal insufficiency

428

Uraemia

1073

Uraemia

722

C

M

Current SOC Key 1 2

Action2

2477

New Term Type1

Hypersthenuria

Current Term Type1

1082

New LLT Key

Increased urine concentration

New LLT

906

Current LLT Key

Urine abnormalities

New PT Key

26 2

New PT Term

Renal and urinary investigations

Current PT Key

Current Preferred Term (PT)

110

New HLT Term

Urinary tract disorders

Current HLT Key

New HLT Key

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

15

Current System Organ Class (SOC) Term Renal and urinary disorders

Change no. 146

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 26/41

Current Low Level Term (LLT)

C

M

153

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Urine abnormalities NOS

907

Abnormal urine odour

1966

C

M

154

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urine abnormalities

906

Urine abnormalities NOS

907

Discoloured urine

1964

C

M

155

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urolithiasis

440

Calculi

741

C

M

156

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urolithiasis

440

Crystalluria

2028

C

M

157

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urolithiasis

440

NT - pelvic lithiasis

2374

C

M

Current SOC Key 1 2

Action2

2256

New Term Type1

Uric acid crystals

Current Term Type1

1087

New LLT Key

Uric acid crystals

New LLT

440

Current LLT Key

Urolithiasis

New PT Key

26 2

New PT Term

Current PT Key

Renal and urinary investigations

New HLT Key

110

New HLT Term

Urinary tract disorders

Current HLT Key

Current Preferred Term (PT)

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

15

Current System Organ Class (SOC) Term Renal and urinary disorders

Change no. 152

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 27/41

Current Low Level Term (LLT)

159

Renal and urinary disorders

15

Investigations

34

Urinary tract disorders

110

Renal and urinary investigations

26 2

Urolithiasis

440

Urolithiasis

740

C

M

Investigations

34

Renal and urinary investigations

26 2

Urine abnormalities NOS

907

Current SOC Key

160

161

Reproductive system disorders

16

Investigations

34

Fertility disorders

118

Reproductive investigations

26 3

Abnormal spermatozoa

451

Abnormal spermatozoa NOS

451

Abnormal spermatozoa

763

162

Reproductive system disorders

16

Investigations

34

Fertility disorders

118

Reproductive investigations

26 3

Abnormal spermatozoa

451

Abnormal spermatozoa NOS

451

Decreased spermatozoa motility

163

Reproductive system disorders

16

Investigations

34

Fertility disorders

118

Reproductive investigations

26 3

Abnormal spermatozoa

451

Decreased number of spermatozoa

1088

Decreased number of spermatozoa

1 2

Active urine sediment

2699

Abnormal spermatozoa NOS

763

C

Action2 M

New Term Type1

C

Current Term Type1

1959

New LLT Key

Urine abnormalities NOS

New LLT

907

Current LLT Key

Urine abnormalities NOS

New PT Key

26 2

New PT Term

Renal and urinary investigations

Current PT Key

Current Preferred Term (PT)

110

New HLT Term

Urinary tract disorders

Current HLT Key

New HLT Key

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

15

Current System Organ Class (SOC) Term Renal and urinary disorders

Change no. 158

A

C

M

2128

C

M

2129

C

M

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 28/41

34

Residues

235

Residue investigations

26 9

Residues

929

Residues in eggs

166

Systemic disorders

19

Investigations

34

Residues

235

Residue investigations

26 9

Residues

929

167

Systemic disorders

19

Investigations

34

Residues

235

Residue investigations

26 9

Residues

168

Systemic disorders

19

Investigations

34

Residues

235

Residue investigations

26 9

169

Systemic disorders

19

Investigations

34

Residues

235

Residue investigations

26 9

Current SOC Key 1 2

Action2

Investigations

New Term Type1

19

Current Term Type1

Systemic disorders

New LLT Key

165

New LLT

954

Current LLT Key

High oestrogen level

Current Low Level Term (LLT)

26 3

New PT Key

Reproductive investigations

New PT Term

Current Preferred Term (PT)

119

Current PT Key

New HLT Key

Gonadotrophin and sex hormone changes

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

16

Current System Organ Class (SOC) Term Reproductive system disorders

Change no. 164

High oestrogen level

2132

C

M

1102

Residues in eggs

2040

A

M

Residues in honey

1103

Residues in honey

2041

A

M

929

Residues in meat/offal

1104

Residues in meat/offal

2042

A

M

Residues

929

Residues in milk

1105

Residues in milk

2043

A

M

Residues

929

Residues NOS

1106

Residues NOS

2044

A

M

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 29/41

Current Low Level Term (LLT)

Change in blood protein

909

Abnormal serum protein NOS

1032

Change in blood protein NOS

2220

171

Blood and lymphatic system disorders

3

Investigations

34

Other blood disorders

19

Serum protein investigations

25 1

Change in blood protein

909

Elevated globulins

1033

Elevated globulins

172

Blood and lymphatic system disorders

3

Investigations

34

Other blood disorders

19

Serum protein investigations

25 1

Change in blood protein

909

Hyperalbuminaemia

1034

173

Blood and lymphatic system disorders

3

Investigations

34

Other blood disorders

19

Serum protein investigations

25 1

Change in blood protein

909

Hyperproteinaemia

174

Blood and lymphatic system disorders

3

Investigations

34

Other blood disorders

19

Serum protein investigations

25 1

Change in blood protein

909

175

Blood and lymphatic system disorders

3

Investigations

34

Other blood disorders

19

Serum protein investigations

25 1

Change in blood protein

909

2

M

Hyperalbuminaemia

2154

C

M

1035

Hyperproteinaemia

2155

C

M

Hypoalbuminaemia

1036

Hypoalbuminaemia

1883

C

M

Hypoproteinaemia

1037

Hypoproteinaemia

1976

C

M

Action2

C

Abnormal serum protein NOS

New Term Type1

2556

New LLT

M

Current LLT Key

C

New PT Key

2220

New PT Term

Current SOC Key 1

Current Term Type1

25 1

New LLT Key

Serum protein investigations

Current PT Key

Current Preferred Term (PT)

19

New HLT Term

Other blood disorders

Current HLT Key

New HLT Key

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

3

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 170

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 30/41

Current Low Level Term (LLT)

C

M

177

Blood and lymphatic system disorders

3

Investigations

34

Other blood disorders

19

Serum protein investigations

25 1

Change in blood protein

909

Reduced globulins

1039

Reduced globulins

2557

C

M

178

Investigations

34

Synovial fluid investigations

27 4

Synovial fluid, abnormal NOS

1127

Synovial fluid, abnormal NOS

2721

C

A

179

Investigations

34

Synovial fluid investigations

27 4

Synovial fluid, high protein level

1128

Synovial fluid, high protein level

2722

C

A

180

Investigations

34

Synovial fluid investigations

27 4

Synovial fluid, high red blood cell count

1129

Synovial fluid, high red blood cell count

2723

C

A

181

Investigations

34

Synovial fluid investigations

27 4

Synovial fluid, high white blood cell count

1130

Synovial fluid, high white blood cell count

2724

C

A

Current SOC Key 1 2

Action2

2117

New Term Type1

Inversion of albumin/globulin ratio

Current Term Type1

1038

New LLT Key

Inversion of albumin/globulin ratio

New LLT

909

Current LLT Key

Change in blood protein

New PT Key

25 1

New PT Term

Serum protein investigations

Current PT Key

Current Preferred Term (PT)

19

New HLT Term

Other blood disorders

Current HLT Key

New HLT Key

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

3

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 176

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 31/41

Current Low Level Term (LLT)

2424

C

M

183

Blood and lymphatic system disorders

3

Investigations

34

Disorders of platelets and coagulopathies

15

Thrombocyte investigations

24 8

Platelet disorder NOS

985

Large platelets

1027

Large platelets

2425

C

M

184

Blood and lymphatic system disorders

3

Investigations

34

Disorders of platelets and coagulopathies

15

Thrombocyte investigations

24 8

Thrombocytopenia

95

Low platelet count

161

C

M

185

Blood and lymphatic system disorders

3

Investigations

34

Disorders of platelets and coagulopathies

15

Thrombocyte investigations

24 8

Platelet disorder NOS

985

Platelet disorder NOS

2423

C

M

186

Blood and lymphatic system disorders

3

Investigations

34

Disorders of platelets and coagulopathies

15

Thrombocyte investigations

24 8

Thrombocytopenia

95

Thrombocytopenia

160

C

M

187

Blood and lymphatic system disorders

3

Investigations

34

Disorders of platelets and coagulopathies

15

Thrombocyte investigations

24 8

Thrombocytosis

949

Thrombocytosis

2116

C

M

Current SOC Key 1 2

Action2

Giant platelets

New Term Type1

1027

Current Term Type1

Large platelets

New LLT Key

985

New LLT

Platelet disorder NOS

Current LLT Key

24 8

New PT Key

Thrombocyte investigations

New PT Term

Current Preferred Term (PT)

15

Current PT Key

New HLT Key

Disorders of platelets and coagulopathies

Current HLT Key

New HLT Term

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

3

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 182

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 32/41

Action2 A

189

Investigations

34

Thyroid investigations

25 6

Abnormal thyroidrelated autoantibodies

1121

Abnormal thyroglobulin autoantibodies (TgAA)

2706

C

A

190

Investigations

34

Thyroid investigations

25 6

Abnormal thyroidrelated autoantibodies

1121

Abnormal triiodothyronine autoantibodies (T3AA)

2707

C

A

191

Investigations

34

Thyroid investigations

25 6

Abnormal thyroidrelated autoantibodies

1121

Abnormal thyroxine autoantibodies (T4AA)

2708

C

A

192

Investigations

34

Thyroid investigations

25 6

Elevated T4 (thyroxine)

1048

Elevated T4 (thyroxine)

2669

C

A

193

Investigations

34

Thyroid investigations

25 6

High triiodothyronine (T3)

1122

High free triiodothyronine (FT3)

2709

C

A

1 2

New LLT Key

C

New LLT

2668

Current LLT Key

Abnormal thyroid stimulating hormone (TSH) level

New PT Key 1049

New PT Term Abnormal thyroid stimulating hormone (TSH)

Current PT Key

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

New HLT Key 25 6

Current HLT Key

Thyroid investigations

New SOC Key 34

New SOC Term

New HLT Term

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term

Investigations

Change no. 188

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 33/41

Action2 A

195

Investigations

34

Thyroid investigations

25 6

Low T4 (thyroxine)

1050

Low thyroxine (T4 )

2670

C

A

196

Investigations

34

Thyroid investigations

25 6

Low triiodothyronine (T3)

1123

Low free triiodothyronine (FT3)

2711

C

A

197

Investigations

34

Thyroid investigations

25 6

Low triiodothyronine (T3)

1123

Low triiodothyronine (T3)

2712

C

A

198

Investigations

34

Thyroid investigations

25 6

Abnormal thyroid stimulating hormone (TSH)

104 9

High thyroid stimulating hormone (TSH)

2703

C

A

199

Investigations

34

Thyroid investigations

25 6

High thyroxine (T4)

104 8

High free thyroxine (FT4)

2704

C

A

1 2

New LLT Key

C

New LLT

2710

Current LLT Key

High triiodothyronine (T3)

New PT Key 1122

New PT Term High triiodothyronine (T3)

Current PT Key

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

New HLT Key 25 6

Current HLT Key

Thyroid investigations

New SOC Key 34

New SOC Term

New HLT Term

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term

Investigations

Change no. 194

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 34/41

201

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Leucocytosis

97

Leucocytosis NOS

97

Leucocytosis

163

202

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Leucocytosis

97

Monocytosis

1031

Monocytosis

203

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Basophilia

968

204

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Eosinophilia

205

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Leucopenia

1 2

Leucocytosis NOS

163

Action2

2705

New Term Type1

Low free thyroxine (FT4)

Current Term Type1

New LLT Key

New LLT

105 0

Current LLT Key

Low thyroxine (T4)

Current Low Level Term (LLT)

25 6

New PT Key

Current PT Key

Thyroid investigations

New PT Term

Current Preferred Term (PT)

Current HLT Key

New HLT Key

34

New HLT Term

Investigations

Current High Level Term (HLT)

New SOC Key

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no. 200

C

A

C

M

2420

C

M

Basophilia

2219

C

M

96

Eosinophilia

162

C

M

98

Leucopenia

164

C

M

Leucopenia NOS

164

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 35/41

Current Low Level Term (LLT)

207

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Lymphopenia

100

Lymphopenia

166

C

M

208

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Neutropenia

101

Neutropenia

167

C

M

209

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Neutrophilia

102

Neutrophilia

168

C

M

210

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Panleucopenia

103

Panleucopenia

169

C

M

211

Blood and lymphatic system disorders

3

Investigations

34

Disorders of white blood cells

16

White blood cell investigations

25 0

Stress leukogram

101 2

Stress leukogram

2589

C

M

Current SOC Key 1 2

Action2 M

New Term Type1

C

Current Term Type1

165

New LLT Key

Lymphocytosis

New LLT

99

Current LLT Key

Lymphocytosis

New PT Key

25 0

New PT Term

Current PT Key

White blood cell investigations

New HLT Key

16

New HLT Term

Disorders of white blood cells

Current HLT Key

Current Preferred Term (PT)

Current High Level Term (HLT)

34

New SOC Key

Investigations

New SOC Term

3

Current System Organ Class (SOC) Term Blood and lymphatic system disorders

Change no. 206

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 36/41

Action2

Musculoskeletal disorders

13

Musculoskeletal disorders

90

Lameness

378

Hip dysplasia

2725

C

A

214

Musculoskeletal disorders

13

Musculoskeletal disorders

90

Musculoskeletal disorder NOS

640

Difficulty to rise

2726

C

A

215

Neurological disorders

14

Convulsions and epilepsy

97

Epileptic seizure

398

Grand mal seizure

2727

C

A

216

Neurological disorders

14

Neurological disorders NOS

219

Neurological disorder NOS

812

Neurological disorder NOS

2728

C

A

217

Neurological disorders

14

Peripheral neuropathies and neuritis

103

Peripheral nerve injury

831

Peripheral nerve injury

2747

C

A

1 2

New LLT Key

213

New LLT

A

Current LLT Key

C

New PT Key

2745

New PT Term

Lactation change NOS

Current PT Key 950

New HLT Key

Lactation change

New HLT Term

76

Current HLT Key

Milk production disorders

New SOC Key

11

New SOC Term

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term Mammary gland disorders

Change no. 212

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 37/41

Action2

New Term Type1

Current Term Type1

New LLT Key

New LLT

Current LLT Key

Current Low Level Term (LLT)

New PT Key

New PT Term

Current PT Key

Current Preferred Term (PT)

New HLT Key

New HLT Term

Current HLT Key

Current High Level Term (HLT)

New SOC Key

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no. 218

Renal and urinary disorders

15

Urinary tract disorders

110

Urine abnormalities

906

Urinary tract bleeding

1085

Urinary tract bleeding

1965

C

M

219

Renal and urinary disorders

15

Urinary tract disorders

110

Urine abnormalities

906

Urinary tract infection

1086

Urinary tract infection

2026

C

M

220

Respiratory tract disorders

17

Bronchial and lung disorders

132

Atelectasis

991

221

Skin and appendages disorders

18

Skin and appendages neoplasms

146

222

Skin and appendages disorders

18

Skin and subcutaneous tissue disorders

238

Skin haemorrhage

223

Skin and appendages disorders

18

Sweating disorders

149

Miliaria

1 2

Atelectasis

2749

C

A

Mast cell tumour

2729

C

A

848

Skin haemorrhage NOS

2748

C

A

553

Miliaria

2746

C

A

Mast cell tumour

1131

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 38/41

Action2

Systemic disorders

19

Bee systemic disorders

241

Bee systemic disorder NOS

960

Bee brood death

2731

A

A

226

Systemic disorders

19

Bee systemic disorders

241

Bee systemic disorder NOS

960

Bee brood mortality

2732

A

A

227

Systemic disorders

19

Bee systemic disorders

241

Bee systemic disorder NOS

960

Bee colony death

2733

A

A

228

Systemic disorders

19

Bee systemic disorders

241

Bee systemic disorder NOS

960

Bee wing deformation

2734

A

A

229

Systemic disorders

19

Bee systemic disorders

241

Bee systemic disorder NOS

960

Hive weakness

2735

A

A

1 2

New LLT Key

225

New LLT

A

Current LLT Key

A

New PT Key

2730

New PT Term

Decreased egglaying (bees)

Current PT Key 960

New HLT Key

Bee systemic disorder NOS

New HLT Term

241

Current HLT Key

Bee systemic disorders

New SOC Key

19

New SOC Term

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term Systemic disorders

Change no. 224

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 39/41

Action2

Systemic disorders

19

Bee systemic disorders

241

Bee systemic disorder NOS

960

Queen bee death

2737

A

A

232

Systemic disorders

19

Bee systemic disorders

241

Bee systemic disorder NOS

960

Queen bee loss

2738

A

A

233

Systemic disorders

19

Bee systemic disorders

241

Bee systemic disorder NOS

960

Queen bee rejection

2739

A

A

234

Systemic disorders

19

General signs or symptoms

154

Abnormal test result

666

235

Systemic disorders

19

General signs or symptoms

154

Anorexia

598

1 2

Sick euthyroid syndrome

1117

Sick euthyroid syndrome

New LLT Key

231

New LLT

A

Current LLT Key

A

New PT Key

2736

New PT Term

Loss of egg quantity (bees)

Current PT Key 960

New HLT Key

Bee systemic disorder NOS

New HLT Term

241

Current HLT Key

Bee systemic disorders

New SOC Key

19

New SOC Term

New Term Type1

Current Term Type1

Current Low Level Term (LLT)

Current Preferred Term (PT)

Current High Level Term (HLT)

Current SOC Key

Current System Organ Class (SOC) Term Systemic disorders

Change no. 230

2507

C

Off food

2740

M

C

A

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 40/41

New Term Type1

Action2

Increased skin temperature

2691

C

A

1132

Cold feeling to the touch

2741

C

A

Low skin temperature

1132

Low skin temperature

2744

C

A

Lying down

1134

Lying down

2743

C

A

19

General signs or symptoms

154

237

Systemic disorders

19

General signs or symptoms

154

Increased skin temperature

1133

Warm feeling to the touch

238

Systemic disorders

19

General signs or symptoms

154

Increased skin temperature

1133

239

Systemic disorders

19

General signs or symptoms

154

Low skin temperature

240

Systemic disorders

19

General signs or symptoms

154

241

Systemic disorders

19

General signs or symptoms

154

2

New LLT Key

A

Discomfort NOS

New LLT

C

994

Current LLT Key

Current Term Type1

Current Low Level Term (LLT)

2742

New PT Key

M

New PT Term

Current PT Key

Current Preferred Term (PT)

New HLT Key

New HLT Term

Current HLT Key

Current High Level Term (HLT)

New SOC Key

New SOC Term

Current SOC Key

Current System Organ Class (SOC) Term

Change no.

C

Systemic disorders

1

Discomfort NOS

A

236

2498

: A: animal; C: common; H: human : A: addition; D: deletion; M: modification

List of changes to combined VeDDRA list of clinical terms EMA/CVMP/PhVWP/272687/2018

Page 41/41

List of changes to combined VeDDRA list of clinical terms - European ...

Jun 21, 2018 - 308. Elevated total biliru- bin. 1055 Elevated total biliru- bin. 2052. C. M. 70. Renal and urinary dis- ...... min/globulin ratio. 1038 Inversion of.

227KB Sizes 0 Downloads 133 Views

Recommend Documents

(VeDDRA) list of clinical terms for reporting suspected adverse
Jun 15, 2017 - NT: Necropsy term. 1: A: animal; C: common; H: human. Combined VeDDRA list of clinical terms for reporting suspected adverse reactions in animals and humans to veterinary medicinal products. EMA/CVMP/PhVWP/10418/2009-Rev.9. Page 2/153.

(VeDDRA) list of clinical terms for reporting suspected adverse
Jun 15, 2017 - 66. Hepatopathy. 308. Elevated bile acids. 2051 ..... Acid-base disorder. 337. Acid-base disorder ...... 154. Lethargy. 606. Loss of strength. 1594.

(VeDDRA) list of clinical terms for reporting suspected adverse
Jun 15, 2017 - 1836. Respiratory tract disorders. 17. Bronchial and lung disorders. 132. Rale. 514. Crackles on auscultation 2140. C. 1837. Respiratory tract disorders. 17. Bronchial and lung disorders. 132. Rale. 514. Crepitation on auscultation. 21

(VeDDRA) list of - European Medicines Agency - Europa EU
Jun 15, 2017 - List of changes to combined VeDDRA list of clinical terms. For reporting suspected .... Mental impair- ment. 217. Mental confusion. 747. Disorienta- tion. 401. Disoriented state. 1418. C. M ... cal disorder (see also 'Behavioural.

List of eligible industry stakeholder organisations - European ...
Jan 27, 2017 - Website. Active Pharmaceutical Ingredients Committee. APIC http://apic.cefic.org/. Association of Clinical Research Organizations. ACRO.

Jess' big list of gender terms 2.0.pdf
Page 1 of 7. • AFAB/FAAB: Assigned female at birth and female assigned at birth respectively. These terms. refer to what gender you were assigned at birth (in this case female, thus you are expected to be. a girl/woman), and are important because m

TERMS Mail List 1.pdf
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. TERMS Mail List ...

List of Award Winners
Apr 7, 2016 - Cheryl Lewis, CCC, CCE, chef instructor, Le Cordon Bleu College of ... lead baking instructor, Pulaski Technical College Culinary Arts and ...

List of Colleges:
135166 Banga Bandhu Science And Information Technology Bm Institute. 24120. Banga Bandhu Shaikh Mujib College. 134874 Banga Mata Begum Fazilatunnesa Mujib Womens' College ..... 136307 Capital College. 134501 Captain (Retd.) Giasuddin Ahmed College. 5

rupatadine: List of nationally authorised ... - European Medicines Agency
Sep 1, 2017 - Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency ... Product Name (in authorisation country). MRP/ ...

buspirone: List of nationally authorised ... - European Medicines Agency
Jan 11, 2018 - ACCORD HEALTHCARE. LIMITED. UK. BUSPAR TABLETS 5MG not available. PL 20075/0559. ACCORD HEALTHCARE. LIMITED. UK. Itagil 10 mg comprimido not available. 4509584. AUROVITAS UNIPESSOAL,. LDA. PT. Itagil 10 mg comprimido not available. 877

sulbactam: List of nationally authorised ... - European Medicines Agency
Sep 1, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website www.ema.europa.eu/contact. © European ...

triptorelin - List of nationally authorised ... - European Medicines Agency
Nov 30, 2017 - HU. Gonapeptyl 0,1 mg/ml oldatos injekció. NL/H/1427/001. OGYI-T-21047/01. FERRING MAGYARORSZÁG. GYÓGYSZERKERESKEDELMI.

Dienogest: List of nationally authorised ... - European Medicines Agency
Sep 1, 2017 - Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency, 2017 ... Product name. (in authorisation country).

Annual list of contractors 2016 - contract values - European Medicines ...
Jun 28, 2016 - paragraph 3 of the Rules of Application of the general Financial Regulation refers) to publish on its external website a ... Bibliographic database.

List of nationally authorised medicinal products - European Medicines ...
Jan 11, 2018 - LARGACTIL not available. PL 04425/0582. AVENTIS PHARMA LTD. UK. LARGACTIL 100 mg, comprimé pelliculé sécable not available. 305 712-4. SANOFI-AVENTIS FRANCE. FR. LARGACTIL 25 mg, comprimé pelliculé sécable not available. 305 711-

List of nationally authorised medicinal products - European Medicines ...
Jul 19, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation country) .... not available. 19158.

List of nationally authorised medicinal products - European Medicines ...
Sep 29, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name ... EKISTOL 50 mg comprimidos not available.

List of nationally authorised medicinal products - European Medicines ...
Jan 11, 2018 - List of nationally authorised medicinal products. EMA/24585/2018. Page 2/8. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the member state. Member State where p

List of nationally authorised medicinal products - European Medicines ...
Jun 21, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in ... Sinemet retard-Tabletten not available.

List of Colleges:
Gopalpur Technical College. 103384 Gopinathpur Al- Haj Shah Alam College, Kasba, Brahmanbaria. 118029 Gopinathpur M. A. Khaleque School And College. 134371 Gopinathpur Technical And Business Management College. 27069. Gorai Girls College. 107623 Gora

List of medicinal products under additional monitoring - European ...
ALK-Abelló A/S https://portal.dimdi.de/amispb/doc/pei/Web/2613318-spcde- · 20170401.pdf. May 2016 ... conditional authorisation. Roche Registration Limited.